Sustained activation of NLRP3 inflammasome and release of neutrophil extracellular traps (NETs) impair wound healing of diabetic foot ulcers (DFUs). Our previous study reported that milk fat globule epidermal growth factor VIII (MFG-E8) attenuates tissue damage in systemic lupus erythematosus. However, the functional effect of MFG-E8 on “NLRP3 inflammasome-NETs” inflammatory loop in wound healing of diabetes is not completely elucidated. In this study, neutrophils from DFU patients are susceptible to undergo NETosis, releasing more NETs. The circulating levels of NET components neutrophil elastase and proteinase 3 and inflammatory cytokines IL-1β and IL-18 were significantly elevated in DFU patients compared with healthy controls or diabetic patients, in spite of higher levels of MFG-E8 in DFU patients. In Mfge8−/− diabetic mice, skin wound displayed exaggerated inflammatory response, including leukocyte infiltration, excessive activation of NLRP3 inflammasome (release of higher IL-1β, IL-18, and TNF-α), largely lodged NETs, resulting in poor angiogenesis and wound closure. When stimulated with high-dose glucose or IL-18, MFG-E8-deficient neutrophils release more NETs than WT neutrophils. After administration of recombinant MFG-E8, IL-18-primed NETosis of WT or Mfge8−/− neutrophils was significantly inhibited. Furthermore, NET and mCRAMP (component of NETs, the murine equivalent of cathelicidin LL-37 in human)-mediated activation of NLRP3 inflammasome and production of IL-1β/IL-18 were significantly elevated in Mfge8−/− macrophages compared with WT macrophages, which were also significantly dampened by the administration of rmMFG-E8. Therefore, our study demonstrated that as inhibitor of the “NLRP3 inflammasome-NETs” inflammatory loop, exogenous rMFG-E8 improves angiogenesis and accelerates wound healing, highlighting possible therapeutic potential for DFUs.
Angiopoietin-like 8 (ANGPTL8) is closely linked to obesity-associated
metabolic diseases and insulin resistance. The aim of the current study was
to investigate the ability of ANGPTL8 to reverse insulin resistance in obese
mice. The administration of ANGPTL8 reduced weight gain and improved glucose
tolerance in mice with diet-induced obesity. In addition, ANGPTL8
administration modified macrophage infiltration, reduced monocyte
chemoattractant protein-1 (MCP-1) and interleukin-1β(IL-1β)
levels, and increased adiponectin gene expression in inguinal white adipose
tissue (iWAT). Moreover, the exposure of a cultured peritoneal macrophage
line to ANGPTL8 reduced the mRNA expression of M1 macrophage markers
(TNF-α and IL-1β) upon stimulation with lipopolysaccharides
in a dose-dependent manner. By contrast, when incubated with IL-4, exposure
of macrophages to ANGPTL8 increased the mRNA expression of M2 macrophage
markers (Arg1 and Chi3l3) in a dose-dependent manner. Collectively, the
results of the present study demonstrated that treatment with ANGPTL8 can
attenuate adipose tissue inflammation through regulation of macrophage
polarization, and thus, it could be useful for improving insulin
resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.